Triple Primary Malignancies: Tumor Associations, Survival, and Clinicopathological Analysis: A 25-Year Single-Institution Experience

Author:

Almasan Iulia12ORCID,Piciu Doina12ORCID

Affiliation:

1. Department of Endocrine Tumors and Nuclear Medicine, Institute of Oncology, 400015 Cluj-Napoca, Romania

2. Ph.D. School of Iuliu Hațieganu, University of Medicine and Pharmacy, 400347 Cluj-Napoca, Romania

Abstract

The detection of multiple primary malignancies is on the rise despite their rare occurrence rate. This research aims to determine the prevalence, tumor association patterns, overall survival, and the correlation between survival time and independent factors in patients with triple primary malignancies. This single-center retrospective study included 117 patients with triple primary malignancies admitted to a tertiary cancer center between 1996 and 2021. The observed prevalence was 0.082%. The majority of patients (73%) were over the age of fifty at the first tumor diagnosis, and regardless of gender, the lowest median age occurred in the metachronous group. The most common tumor associations were found between genital–skin–breast, skin–skin–skin, digestive–genital–breast, and genital–breast–lung cancer. The male gender and being over the age of fifty at the first tumor diagnosis are associated with a higher risk of mortality. Compared with the metachronous group, patients with three synchronous tumors demonstrate a risk of mortality 6.5 times higher, whereas patients with one metachronous and two synchronous tumors demonstrate a risk of mortality three times higher. The likelihood of subsequent malignancies should always be considered throughout cancer patients’ short- and long-term surveillance to ensure prompt tumor diagnosis and treatment.

Publisher

MDPI AG

Subject

Health Information Management,Health Informatics,Health Policy,Leadership and Management

Reference53 articles.

1. Billroth, T. (1889). Die Allgemeine Chirurgische Pathologie UND Therapie, G. Reimer Publisher.

2. Multiple primary malignant tumors—Survey of literature and statistical study;Warren;Amer. J. Cancer,1932

3. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA Cancer J. Clin.,2021

4. Cancer Statistics, 2021;Siegel;CA Cancer J. Clin.,2021

5. Multiple Primary Malignant Neoplasms: Case Report and a Comprehensive Review of the Literature;Demandante;Am. J. Clin. Oncol.,2003

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3